The press is talking
about Methinks
Exciting times ahead,
keep an eye on us.
Latest
As seen in
Press Release
Methinks achieves ENS cybersecurity certification
February 19, 2026
This is some text inside of a div block.
Press Release
Methinks achieves ENS cybersecurity certification
February 19, 2026
This is some text inside of a div block.
Press Release
Methinks AI Secures Second FDA Clearance, Expanding its Stroke Detection Solution to Contrast Imaging
October 9, 2025
This is some text inside of a div block.
Press Release
Methinks AI Secures Second FDA Clearance, Expanding its Stroke Detection Solution to Contrast Imaging
October 9, 2025
This is some text inside of a div block.
Press Release
Methinks and Siemens Healthineers have signed an agreement to explore collaboration
October 2, 2025
This is some text inside of a div block.
Press Release
Methinks and Siemens Healthineers have signed an agreement to explore collaboration
October 2, 2025
This is some text inside of a div block.
Health Industry Watch
Methinks AI receives FDA 510(k) clearance to expand the frontiers of Non-Contrast CT for stroke triage
July 1, 2025
This is some text inside of a div block.
Health Industry Watch
Methinks AI receives FDA 510(k) clearance to expand the frontiers of Non-Contrast CT for stroke triage
July 1, 2025
This is some text inside of a div block.
La Vanguardia
La Dra. Cocho apuesta por inteligencia artificial de Methinks para la detección temprana de ictus
July 2, 2025
This is some text inside of a div block.
La Vanguardia
La Dra. Cocho apuesta por inteligencia artificial de Methinks para la detección temprana de ictus
July 2, 2025
This is some text inside of a div block.
Circulo Ecuestre
Methinks AI gana el Premio Círculo Ecuestre Joven Relevante 2025
May 16, 2025
This is some text inside of a div block.
Circulo Ecuestre
Methinks AI gana el Premio Círculo Ecuestre Joven Relevante 2025
May 16, 2025
This is some text inside of a div block.
Neuro News
Methinks chosen for patient selection in the Done Symple Trial to expand treatment window
April 22, 2025
This is some text inside of a div block.
Neuro News
Methinks chosen for patient selection in the Done Symple Trial to expand treatment window
April 22, 2025
This is some text inside of a div block.
Controller / METHINKS SOFTWARE S.L. (METHINKS)
Purpose / Subscribing to the Newsletter.
Legal Bases / Express consent.
Storage Period / The data will be kept for the time necessary to fulfill the purposes collected, as well as for the fulfillment of legal obligations.
Rights / You have the right to request from us access, rectification or erasure of your personal data, the right to restrict processing and object to processing at dpo@methinks.ai.
Additional Information / Additional and detailed information on Data Protection can be found in the attached clauses in Privacy Policy.
Responsable / METHINKS SOFTWARE S.L. (METHINKS)
Finalidad / Contactar con el usuario.
Base Legal/ Consentimiento expreso.
Periodo de Conservación / Los datos serán conservados durante el tiempo necesario para cumplir con la finalidad de la recogida, así como para cumplir con las obligaciones legales.
Derechos / Tienes derecho a solicitarnos el acceso, rectificación o supresión de tus datos personales, el derecho a restringir el tratamiento y a retirar el consentimiento en dpo@methinks.ai.
Información Adicional / La información adicional y detallada sobre protección de datos puede encontrarse en Política de Privacidad.